FLUOROPHARMA MEDICAL, INC.
company.status.inactiveCIK 1402785fmd_1A9Z6D6ZBHTK146FWDQ49KE8P1Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2004 to Dec 31, 2016, 33 periods
Latest annual · FY2016
Millions- Operating income
- (2)
- Net income
- (2)
- Free cash flow
- (1)
Latest quarter · Q4 FY2016
Millions- Operating income
- (1)
- Net income
- (0)
- Free cash flow
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2011 to FY2016
- n/m
FLUOROPHARMA MEDICAL, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2.2 million | -$3.2 million | 10-K 2017-03-31 · proof | |
| Net income | -$2 million | -$3.2 million | 10-K 2017-03-31 · proof | |
| Cash from operating activities | -$880,121 | -$2.7 million | 10-K 2017-03-31 · proof | |
| Free cash flow | -$881,414 | -$2.7 million | 10-K 2017-03-31 · proof | |
| Total assets | $334,760 | $838,598 | -60.1% | 10-K 2017-03-31 · proof |
| Total liabilities | $10.5 million | $8.7 million | +20.9% | 10-K 2017-03-31 · proof |
| Cash and cash equivalents | $24,723 | $290,847 | -91.5% | 10-K 2017-03-31 · proof |
- What was FLUOROPHARMA MEDICAL, INC.'s operating income in fiscal 2016?
- FLUOROPHARMA MEDICAL, INC. reported operating income of -$2.2 million for fiscal 2016 (the year ended Dec 31, 2016), against -$3.2 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2017. SEC
- What was FLUOROPHARMA MEDICAL, INC.'s net income in fiscal 2016?
- FLUOROPHARMA MEDICAL, INC. reported net income of -$2 million for fiscal 2016 (the year ended Dec 31, 2016), against -$3.2 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2017. SEC
- What was FLUOROPHARMA MEDICAL, INC.'s cash from operating activities in fiscal 2016?
- FLUOROPHARMA MEDICAL, INC. reported cash from operating activities of -$880,121 for fiscal 2016 (the year ended Dec 31, 2016), against -$2.7 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2017. SEC
- What was FLUOROPHARMA MEDICAL, INC.'s free cash flow in fiscal 2016?
- FLUOROPHARMA MEDICAL, INC. reported free cash flow of -$881,414 for fiscal 2016 (the year ended Dec 31, 2016), against -$2.7 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2017. SEC
- What are FLUOROPHARMA MEDICAL, INC.'s total assets?
- As of Dec 31, 2016, FLUOROPHARMA MEDICAL, INC. reported total assets of $334,760, against $838,598 a year earlier (-60.1%). Source: the 10-K filed with the SEC on Mar 31, 2017. SEC
- What are FLUOROPHARMA MEDICAL, INC.'s total liabilities?
- As of Dec 31, 2016, FLUOROPHARMA MEDICAL, INC. reported total liabilities of $10.5 million, against $8.7 million a year earlier (+20.9%). Source: the 10-K filed with the SEC on Mar 31, 2017. SEC
- What are FLUOROPHARMA MEDICAL, INC.'s cash and cash equivalents?
- As of Dec 31, 2016, FLUOROPHARMA MEDICAL, INC. reported cash and cash equivalents of $24,723, against $290,847 a year earlier (-91.5%). Source: the 10-K filed with the SEC on Mar 31, 2017. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1402785&period_type=annual&limit=5"Information only, not investment advice.